IBIO

iBio, Inc. · NASDAQ · Healthcare · USD · 10-K for 2026, filed 2026-08-28

Figures on this page computed 2026-11-08 13:27 UTC

Last close

0.80USD

Market data, 2026-11-04

IBIO: weekly closes from 1.47 on 2026-05-15 to 0.80 on 2026-11-04, a move of -45.6%. Prices in USD.

Weekly closes, 2026-05-15 to 2026-11-04

Over that span: -45.6%

Except where said otherwise: 10-K for 2026, filed 2026-08-28

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2026
Accession
0001420720-26-000020
Reported in
USD
- computed
- 10-K for 2026, filed 2026-08-28
The filing itself
-111.5%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2026
Accession
0001420720-26-000020
Reported in
USD
- 10-K for 2026, filed 2026-08-28
- 10-K for 2026, filed 2026-08-28
- 10-K for 2026, filed 2026-08-28
- 10-K for 2026, filed 2026-08-28
- 10-K for 2026, filed 2026-08-28
- 10-K for 2026, filed 2026-08-28
The filing itself
-33044.0%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2026
Accession
0001420720-26-000020
Reported in
USD
- 10-K for 2026, filed 2026-08-28
- 10-K for 2026, filed 2026-08-28
The filing itself
-23796.0%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2026
Accession
0001420720-26-000020
Reported in
USD
- 10-K for 2026, filed 2026-08-28
- 10-K for 2026, filed 2026-08-28
The filing itself
0.03Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2026
Accession
0001420720-26-000020
Reported in
USD
- 10-K for 2026, filed 2026-08-28
- 10-K for 2026, filed 2026-08-28
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Growth is the furthest below its sector's middle: 0.10 against 0.50 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

0.11x

1.18x

1.03x

0.15x

0.00x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2026

Market data2026-11-04

Each against its own average

5 of 5 read

Except where said otherwise: 10-K for 2026, filed 2026-08-28

Sales0.11x
Its own average over 10 years, 947.4K.
Profit1.18x
Its own average over 10 years, -28.0M.
Free cash flow1.03x
Its own average over 10 years, -23.2M.
Debt0.15x
Its own average over 5 years, 15.1M.
Price0.00x
Its own average over 11 years, 492. Market data, 2026-11-04

Price is furthest from its own average, at 0.00 times.

The filed years, as a table

Each line is 100 at 2017-06-30, the first year we hold.

Filed year	Sales	Shares in issue
2017-06-30	100.0	n/a
2018-06-30	112.7	n/a
2019-06-30	512.2	n/a
2020-06-30	415.7	n/a
2021-06-30	601.8	100.0
2022-06-30	478.2	111.5
2023-06-30	0.0	156.4
2024-06-30	57.1	979.2
2025-06-30	101.5	2,683.5
2026-06-30	25.4	26,596.8

How sales was got

Source: filed
Statement: income
Fiscal year: 2026
Accession: 0001420720-26-000020
Reported in: USD

The filing itself

How shares in issue was got

Source: filed
Statement: income
Fiscal year: 2026
Accession: 0001420720-26-000020
Reported in: USD

The filing itself

Figures behind the shape

Growth

-46.9%

faster is higher, placed against 4,950 companies as of 2026-11-07

Five-year revenue growth rate-46.9%
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
Five-year EPS growth raten/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
One-year change in net income-79.8%
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Returns on capital

-111.5%

higher is higher, placed against 5,089 companies as of 2026-11-07

Return on invested capital-111.5%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2026
Accession
0001420720-26-000020
Reported in
USD
- 10-K for 2026, filed 2026-08-28
- 10-K for 2026, filed 2026-08-28
- 10-K for 2026, filed 2026-08-28
- 10-K for 2026, filed 2026-08-28
- 10-K for 2026, filed 2026-08-28
- 10-K for 2026, filed 2026-08-28
The filing itself
Return on equity-38.5%
Net Income / Shareholders' Equity x 100
Source
computed
Fiscal year
2026
Accession
0001420720-26-000020
Reported in
USD
- 10-K for 2026, filed 2026-08-28
- 10-K for 2026, filed 2026-08-28
The filing itself
Return on assets-33.3%
Net Income / Total Assets x 100
Source
computed
Fiscal year
2026
Accession
0001420720-26-000020
Reported in
USD
- 10-K for 2026, filed 2026-08-28
- 10-K for 2026, filed 2026-08-28
The filing itself

Margins

-35141.0%

wider is higher, placed against 3,412 companies as of 2026-11-07

Gross marginn/a
We do not hold this figure for this company, so there is nothing to place.
Gross Profit / Revenue x 100
Source
computed
Fiscal year
2026
Accession
0001420720-26-000020
Reported in
USD
- 10-K for 2026, filed 2026-08-28
- 10-K for 2026, filed 2026-08-28
The filing itself
Operating margin-35141.0%
Operating Income / Revenue x 100
Source
computed
Fiscal year
2026
Accession
0001420720-26-000020
Reported in
USD
- 10-K for 2026, filed 2026-08-28
- 10-K for 2026, filed 2026-08-28
The filing itself
Net margin-33044.0%
Net Income / Revenue x 100
Source
computed
Fiscal year
2026
Accession
0001420720-26-000020
Reported in
USD
- 10-K for 2026, filed 2026-08-28
- 10-K for 2026, filed 2026-08-28
The filing itself
Free cash flow margin-23796.0%
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2026
Accession
0001420720-26-000020
Reported in
USD
- 10-K for 2026, filed 2026-08-28
- 10-K for 2026, filed 2026-08-28
The filing itself

Price

0.9x

cheaper is higher, placed against 4,362 companies as of 2026-11-07

Price to earningsn/a
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2026
Accession
0001420720-26-000020
Reported in
USD
- computed
- 10-K for 2026, filed 2026-08-28
The filing itself
Price to book0.9x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
Source
computed
Fiscal year
2026
Accession
0001420720-26-000020
Reported in
USD
- computed
- 10-K for 2026, filed 2026-08-28
- computed
- 10-K for 2026, filed 2026-08-28
The filing itself
EV to EBITDAn/a
We do not hold this figure for this company, so there is nothing to place.
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
Source
computed
Fiscal year
2026
Accession
0001420720-26-000020
Reported in
USD
- computed
- 10-K for 2026, filed 2026-08-28
- 10-K for 2026, filed 2026-08-28
- 10-K for 2026, filed 2026-08-28
- 10-K for 2026, filed 2026-08-28
The filing itself
Price to sales ratio768.6x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
Source
computed
Fiscal year
2026
Accession
0001420720-26-000020
Reported in
USD
- computed
- 10-K for 2026, filed 2026-08-28
- 10-K for 2026, filed 2026-08-28
The filing itself

Safety

0.03

safer is higher, placed against 3,227 companies as of 2026-11-07

Debt to equity0.03
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2026
Accession
0001420720-26-000020
Reported in
USD
- 10-K for 2026, filed 2026-08-28
- 10-K for 2026, filed 2026-08-28
The filing itself
Current ratio7.85
Current Assets / Current Liabilities
Source
computed
Fiscal year
2026
Accession
0001420720-26-000020
Reported in
USD
- 10-K for 2026, filed 2026-08-28
- 10-K for 2026, filed 2026-08-28
The filing itself
Interest coveragen/a
We do not hold this figure for this company, so there is nothing to place.
Operating Income / Interest Expense
Source
computed
Fiscal year
2026
Accession
0001420720-26-000020
Reported in
USD
- 10-K for 2026, filed 2026-08-28
- 10-K for 2026, filed 2026-08-28
The filing itself
Altman Z-Score-1.91
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
Source
computed
Taken on
2026-11-07
Reported in
USD
- Computed from the 10-K for 2026, filed 2026-08-28
- Computed from the 10-K for 2026, filed 2026-08-28
- Computed from the 10-K for 2026, filed 2026-08-28
- Computed from the 10-K for 2026, filed 2026-08-28
- Computed from the 10-K for 2026, filed 2026-08-28

What it pays out

n/a

We do not hold this figure for this company, so there is nothing to place.

more, and better covered, is higher, with no cohort held

Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
Payout ration/a
We do not hold this figure for this company, so there is nothing to place.
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
Source
computed
Fiscal year
2026
Accession
0001420720-26-000020
Reported in
USD
- 10-K for 2026, filed 2026-08-28
- Computed from the 10-K for 2026, filed 2026-08-28
- 10-K for 2026, filed 2026-08-28
The filing itself
Dividend cover ration/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Share a finding

A link to the finding, not to you: it carries nothing about your account.